Scott B. Capps, VP, Clinical Research at CRYOLIFE INC (CRY), sold 14,368 shares at $24.93 ($358K) on 2019-11-26, disclosed to the SEC on 2019-11-27.
Open-market sale of $358k CRY by VP, Clinical Research. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.93 | 7,184 | $179K | 50.0% |
| 2 | $24.93 | 7,184 | $179K | 50.0% |
| Total | $24.93 avg | 14,368 | $358K | 100% |
| Filing → |
| CRY | SELL | 2018-09-04 | $432K | — | Filing → |
| CRY | SELL | 2017-02-24 | $364K | — | Filing → |
| CRY | SELL | 2016-02-23 | $155K | — | Filing → |